ImmunoGen Inc (IMGN)

[XenaLives]

Webcast on January 13th

ImmunoGen Announces Webcast of Presentation and Q&A at the 39th Annual J.P. Morgan Healthcare Conference

Wednesday, December 30th 2020, 4:34 PM EST
WALTHAM, Mass. --(BUSINESS WIRE)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, will present at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference. The presentation is scheduled for 10:50am ET on January 13, 2021.

Following the presentation, Mr. Enyedy will be joined by other members of ImmunoGen’s management team for a question-and-answer session at 11:10am ET.

A webcast of the presentation and question-and-answer session will be accessible live through the “Investors & Media” section of the Company’s website, www.immunogen.com; a replay will be available in the same location

https://www.wfmj.com/story/43114541/immunogen-announces-webcast-of-presentation-and-qa-at-the-39th-annual-jp-morgan-healthcare-conference